BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16428069)

  • 1. CpG oligodinucleotides induce strong humoral and cellular responses to swine streptococcic septicemia vaccine in piglets in vivo.
    Linghua Z; Yong G; Xingshan T; Fengzhen Z
    Int Immunopharmacol; 2006 Mar; 6(3):342-50. PubMed ID: 16428069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo effects of oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to swine streptococcic septicemia vaccine in weaned piglets.
    Linghua Z; Xingshan T; Fengzhen Z
    Mol Immunol; 2007 Feb; 44(6):1141-9. PubMed ID: 16911828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of CpG oligodinucleotides, in combination with conventional adjuvants, as immunological adjuvants to swine streptococcic septicemia vaccine in piglets in vivo.
    Linghua Z; Xingshan T; Fengzhen Z
    Int Immunopharmacol; 2006 Aug; 6(8):1267-76. PubMed ID: 16782539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-administration of porcine-specific CpG oligodeoxynucleotide enhances the immune responses to pseudorabies attenuated virus vaccine in newborn piglets in vivo.
    Linghua Z; Yong G; Xingshan T; Fengzhen Z
    Dev Comp Immunol; 2006; 30(6):589-96. PubMed ID: 16169588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG oligodeoxynucleotides augment the immune responses of piglets to swine Pasteurella multocida living vaccine in vivo.
    Zhang L; Tian X; Zhou F
    Res Vet Sci; 2007 Oct; 83(2):171-81. PubMed ID: 17223146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo effects of oligodeoxynucleotides containing synthetic immunostimulatory motifs in weaned piglets.
    Zhang L; Tian X; Zhou F
    Int Immunopharmacol; 2006 Oct; 6(10):1623-31. PubMed ID: 16919835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets.
    Linghua Z; Xingshan T; Fengzhen Z
    Vaccine; 2008 Jan; 26(2):224-33. PubMed ID: 18063448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with porcine reproductive and respiratory syndrome killed virus vaccine and immunostimulatory oligodeoxynucleotides induces specific immunity in piglets.
    Linghua Z; Xingshan T; Fengzhen Z
    Vaccine; 2007 Feb; 25(10):1735-42. PubMed ID: 17229497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo immunostimulatory effects of CpG ODN in newborn piglets.
    Linghua Z; Xingshan T; Fengzhen Z
    Mol Immunol; 2007 Feb; 44(6):1238-44. PubMed ID: 16908068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal administration of CpG oligonucleotides induces mucosal and systemic Type 1 immune responses and adjuvant activity to porcine reproductive and respiratory syndrome killed virus vaccine in piglets in vivo.
    Zhang L; Tian X; Zhou F
    Int Immunopharmacol; 2007 Dec; 7(13):1732-40. PubMed ID: 17996683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of transgenic expression of porcine interleukin-6 gene and CpG sequences on immune responses of newborn piglets inoculated with Pseudorabies attenuated vaccine.
    Ling-Hua Z; Xing-Shan T; Yong G; Feng-Zhen Z; Min-Jie M
    Res Vet Sci; 2006 Jun; 80(3):281-6. PubMed ID: 16165173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG oligodeoxynucleotide synergizes innate defense regulator peptide for enhancing the systemic and mucosal immune responses to pseudorabies attenuated virus vaccine in piglets in vivo.
    Cao D; Li H; Jiang Z; Cheng Q; Yang Z; Xu C; Cao G; Zhang L
    Int Immunopharmacol; 2011 Jun; 11(6):748-54. PubMed ID: 21310256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic innate defence regulator peptide enhances in vivo immunostimulatory effects of CpG-ODN in newborn piglets.
    Cao D; Li H; Jiang Z; Xu C; Cheng Q; Yang Z; Cao G; Zhang L
    Vaccine; 2010 Aug; 28(37):6006-13. PubMed ID: 20637306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
    Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
    Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosine-phosphate-guanine motifs fail to promote T-helper type 1-polarized responses in human neonatal mononuclear cells.
    Prescott SL; Irwin S; Taylor A; Roper J; Dunstan J; Upham JW; Burgner D; Richmond P
    Clin Exp Allergy; 2005 Mar; 35(3):358-66. PubMed ID: 15784116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulating effects of porcine interleukin-6 gene and CpG motifs on immune responses to porcine trivalent vaccines in mice.
    Wu M; Gao R; Meng M; Li J; Tang M; Shen Y; Wang L; Yin X; Wu X; Xie H; Liu S
    Res Vet Sci; 2004 Aug; 77(1):49-57. PubMed ID: 15120952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunostimulatory DNA activates production of type I interferons and interleukin-6 in equine peripheral blood mononuclear cells in vitro.
    Wattrang E; Berg M; Magnusson M
    Vet Immunol Immunopathol; 2005 Sep; 107(3-4):265-79. PubMed ID: 15955566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The introduction of multi-copy CpG motifs into an antiviral DNA vaccine strongly up-regulates its immunogenicity in fish.
    Martinez-Alonso S; Martinez-Lopez A; Estepa A; Cuesta A; Tafalla C
    Vaccine; 2011 Feb; 29(6):1289-96. PubMed ID: 21134453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine.
    Cooper CL; Davis HL; Morris ML; Efler SM; Krieg AM; Li Y; Laframboise C; Al Adhami MJ; Khaliq Y; Seguin I; Cameron DW
    Vaccine; 2004 Aug; 22(23-24):3136-43. PubMed ID: 15297066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.